Enhanced cancer therapy by the marriage of metabolic alteration and mitochondrial-targeted photodynamic therapy using cyclometalated Ir(iii) complexes.

Jiangping Liu,Chengzhi Jin,Bo Yuan,Yu Chen,Xingguo Liu,Liangnian Ji,Hui Chao
DOI: https://doi.org/10.1039/c7cc05518h
IF: 4.9
2017-01-01
Chemical Communications
Abstract:Herein we present a series of DCA-Ir(III) co-drug complexes that preferentially accumulate in mitochondria and selectively cause cancer cell metabolic alterations and were found to act in synergy by sensitizing cancer cells for PDT to achieve cancer-specific enhanced two-photon PDT in the hypoxic environment of multicellular tumor spheroids.
What problem does this paper attempt to address?